Skip to main content

Invasive Candidiasis in the Intensive Care Setting

  • Chapter
  • First Online:
  • 1491 Accesses

Abstract

Management of Invasive Candidiasis (IC) is one of the hottest topics while caring for critically ill patients: of the utmost importance are clear definitions of the deep-seated invasive infections caused by Candida spp., to have appropriate and correct epidemiological data. Both conventional (hystopathological and microbiological) and newer, nonconventional diagnostic approaches (antigen based biomarkers, molecular tests, genetic tests) will be also shortly reviewed. Predictive rules and clinical scores able to identify patients at a high risk for developing IC infections will be analyzed according to the most recent data. Treatment strategies (prophylaxis, preemptive, empirical, and targeted therapy) according to the most recent definitions and the latest guidelines (IDSA 2010; ESCMID/EFIGS, 2011–2012) will be finally considered.

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Eggimann P, Barberini L, Calandra T, Marchetti O (2012) Invasive candidiasis in the ICU. Mycoses 75:65–72

    Article  Google Scholar 

  2. Leroy O, Gangneux JP, Montravers P et al (2009) Epidemiology, management, and risk factors for death of invasive Candida infections in critical care: a multicenter, prospective, observational study in France (2005–2006). Crit Care Med 37:1612–1618

    Article  PubMed  Google Scholar 

  3. Kollef M, Micek S, Hampton N, Doherty JA, Kumar AS (2012) Septic shock attributed to Candida infection: importance of empiric therapy and source control. Clin Inf Dis 54(12):1739–1746

    Google Scholar 

  4. Kett DH, Azoulay E, Echeverria PM, Vincent JL (2011) Candida bloodstream infections in intensive care units: analysis of the extended prevalence of infection in intensive care unit study. Crit Care Med 39:665–670

    Article  PubMed  Google Scholar 

  5. Playford EG, Lipman J, Sorrell T (2010) Management of invasive candidiasis in the ICU. Drugs 70:823–839

    Google Scholar 

  6. Chalmer CM, Bal AM (2011) Management of fungal infections in the intensive care unit: a survey of UK practice. BJ Anesth 106:827–831

    Google Scholar 

  7. Echeverria PM, Kett DH, Azoulat E (2011) Candida prophylaxix and therapy in ICU. Sem Resp Crit Care Med 32:159–173

    Article  Google Scholar 

  8. Tortorano AM, Dho AM, Prigitano A, Breda G, Grancini A et al (2011) Invasive fungal infections in the intensive care unit: a multicentre,prospective, observational study in Italy (2006–2008). Mycoses 55(1):73–79

    Google Scholar 

  9. Cornely OA, Bassetti M, Calandra T, Garbino J, Kullberg BJ, Lortholary O (2012) et ESCMID*(ESCMID Fungal Infection Study Group, EFIGS) guideline for the diagnosis and management of Candida diseases 2012: non-neutropenic adult patients. Clinical microbiology and infection: the official publication of the European Society of Clinical Microbiology and Infectious Diseases 18(Suppl 7):19–37

    Article  CAS  Google Scholar 

  10. Viale PG (2009) Candida colonization and candiduria in critically ill patients in the intensive care unit. Drugs 69(Suppl. 1):51–57

    Article  PubMed  Google Scholar 

  11. Guzman JA, Tchokonte R, Sobel JD (2011) Septic shock due to candidemia: outcomes and predictors of shock development. J Clin Med Res 3(2):65–71

    Google Scholar 

  12. Eckmann C, Dryden M, Montravers P, Kozlov R, Sganga G (2011) Antimicrobial treatment of complicated intraabdominal infection and the new IDSA guidelines. a commentary and an alternative European approach according to clinical definitions. Eur J Med Res 16:115–126

    Article  PubMed  Google Scholar 

  13. Solomkin JS, Mazuski JE, Bradley JS, Rodvold KA, Goldstein EJC et al (2010) Diagnosis and management of complicated intra-abdominal infection in adults and children: guidelines by the Surgical Infection Society and the Infectious Diseases Society of America. Clin Inf Dis 50:133–164

    Article  Google Scholar 

  14. Blot S, Vandewoude KH, De Waele JJ (2007) Candida peritonitis. Curr Opin Crit Care 13:195–199

    Google Scholar 

  15. Sartelli M, Viale P, Koike K, Pea F, Tumietto F, van Goor H, Guercioni et al (2011) WSES consensus conference: guidelines for first line management of intra-abdominal infections. World J Emerg Surg 6:2

    Google Scholar 

  16. Blot S, De Waele JJ, Vogelaers D (2012) Essentials for selecting antimicrobial therapy for intra-abdominal infections. Drugs 72(6):e17–e32

    Article  PubMed  CAS  Google Scholar 

  17. Carneiro HA, Mavrakis A, Mylonakis E (2011) Candida peritonitis: an update on the latest research and treatments. World J Surg 35:2650–2659

    Article  PubMed  Google Scholar 

  18. Mikulska M, Bassetti M, Romeo S, Viscoli C (2011) Invasive candidiasis in non-hematological patients. Mediterr J Hematol Infect Dis 3(1):e2011007. DOI 10.4084/MJHID.2011.007

  19. Dupont H, Bourichon A, Paugam-Burtz C, Mantz J, Desmont JM (2003) Can yest isolation in peritoneal fluid be predictive in ICU patients with peritonitis? Crit Care Med 31:752–757

    Article  PubMed  Google Scholar 

  20. Hamet M, Pavon A, Dalle F, Pechinot A, Prin S et al (2012) Candida spp. airway colonization could promote antibiotic-resistant bacteria selection in patients with suspected ventilator-associated pneumonia. Intensive Care Med 38:1272–1279

    Google Scholar 

  21. Sobel J (2010) Changing trends in the epidemiology of Candida blood stream infections: a matter for concern ? Crit Care Med 38:990–992

    Google Scholar 

  22. Marriott DJE, Playford EG, Chen S, Slavin M, Nguyen Q et al (2009) Determinants of mortality in non-neutropenic ICU patients with candidaemia. Crit Care 13:R115. doi:10.1186/cc7964

    Article  PubMed  Google Scholar 

  23. Bassetti M, Taramasso L, Nicco E, Molinari MP, Mussap M, Viscoli C (2011) Epidemiology, species distribution, antifungal susceptibility and outcome of nosocomial candidemia in a tertiary care hospital in Italy. PLoS ONE 6(9):e24198. doi:10.1371/journal.pone.0024198

  24. Andes DR, Safdar N, Baddley JW et al (2012) Impact of treatment strategy on outcomes in patients with candidemia and other forms of invasive candidiasis: a patient-level quantitative review of randomized trials. Clin Infect Dis 54:1110–1122

    Article  PubMed  CAS  Google Scholar 

  25. Tumbarello M, Fiori B, Trecarichi EM, Posteraro P, Losito AR et al (2012) Risk factors and outcomes of candidemia caused by biofilm-forming isolates in Tertiary Care Hospital. PLoS ONE 7(3):e33705. doi:10.1371/journal.pone.0033705

  26. Martini A, Gottin L, Menestrina N, Schweiger V, Simion D, Vincent JL (2010) Procalcitonin levels in surgical patients at risk of candidemia. J Infect 60(6):425–430

    Article  PubMed  Google Scholar 

  27. Eggimann P, Bille J, Marchetti O (2011) Diagnosis of invasive candidiasis in the ICU. Ann Int Care 1:37

    Article  Google Scholar 

  28. Posteraro B, De Pascale G, Tumbarello M, Torelli R (2011) Mariano Alberto Pennisi MA et al. Early diagnosis of candidemia in intensive care unit patients with sepsis: a prospective comparison of (1-3)-beta-D-glucan assay, Candida score, and colonization index. Crit Care 15:R249

    Article  PubMed  Google Scholar 

  29. Del Bono V, Delfino E, Furfaro E, Mikulska M, Nicco E et al (2011) Assay in early diagnosis of nosocomial clinical performance of the (1,3)-b-d-Glucan Candida bloodstream infections. Clin Vaccine Immunol 18:2113

    Article  PubMed  Google Scholar 

  30. Eggimann P, Marchetti O (1017) Is (1-3)-β-D-glucan the missing link from bedside assessment to pre-emptive therapy of invasive candidiasis? Crit Care 2011:15

    Google Scholar 

  31. Charles PE, Bruyere R, Dalle F (2012) Early recognition of invasive Candidiasis in the ICU. In: Vincent JL (ed) Annual update in intensive care and emergency medicine. Springer Berlin, pp 311–323

    Google Scholar 

  32. Pittet D, Monod M, Suter PM, Frenk E, Auckenthaler R (1994) Candida colonization and subsequent infections in critically ill surgical patients. Ann Surg 220:751–758

    Article  PubMed  CAS  Google Scholar 

  33. Azoulay E, Dupont H, Tabah A, Lortholary O, Stahl JP et al (2012) Systemic antifungal therapy in critically ill patients without invasive fungal infection. Crit Care Med 40:813–822

    Article  PubMed  CAS  Google Scholar 

  34. Ostrosky-Zeichner L, Pappas PG, Shoham S et al (2011) Improvement of a clinical prediction rule for clinical trials on prophylaxis for invasive candidiasis in the intensive care unit. Mycoses 54:46–51

    Article  PubMed  Google Scholar 

  35. Ostrosky-Zeichner L (2012) Invasive mycoses: diagnostic challenges. Am J Med 125:S14–S24

    Article  PubMed  Google Scholar 

  36. Ostrosky-Zeichner L, Sable C, Sobel J et al (2007) Multicenter retrospective development and validation of a clinical prediction rule for nosocomial invasive candidiasis in the intensive care setting. Eur J Clin Microbiol Infect Dis 26:271–276

    Article  PubMed  CAS  Google Scholar 

  37. Hermsen ED, Zapapas MK, Maiefski M, Rupp M, Freifeld AG, Kalil AC (2011) Validation and comparison of clinical prediction rules for invasive candidiasis in intensive care unit patients: a matched case-control study. Crit Care 15:R198

    Article  PubMed  Google Scholar 

  38. Leon C, Ruiz-Santana S, Saavedra P et al (2006) A bedside scoring system (Candida score) for early antifungal treatment in nonneutropenic critically ill patients with Candida colonization. Crit Care Med 34:730–737

    Article  PubMed  Google Scholar 

  39. Leon C, Ruiz-Santana S, Saavedra P et al (2009) Usefulness of the ‘‘Candida score’’ for discriminating between Candida colonization and invasive candidiasis in non-neutropenic critically ill patients: a prospective multicenter study. Crit Care Med 37:1624–1633

    Article  PubMed  Google Scholar 

  40. Peman J, Zaragoza R (2010) Current diagnostic approaches to invasive candidiasis in critical care settings. Mycoses 53:424–433

    Article  PubMed  CAS  Google Scholar 

  41. Leroy G, Lambiotte F, Thévenin D, Lemaire C, Parmentier E, Devos P, andn Leroy O (2011) Evaluation of “Candida score” in critically ill patients: a prospective, multicenter,observational, cohort study. Ann Intensive Care 1(1):50

    Google Scholar 

  42. Pappas PG, Kauffman CA, Andes D, Benjamin DK, Calandra TF, Edwards JE et al (2009) Clinical practice guidelines for the managementof candidiasis: 2009 update by the Infectious Diseases Society of America (IDSA). Clin Inf Dis 48:503–535

    Google Scholar 

  43. Grossi PA, Dalla Gasperina D, Barchiesi F, Biancofiore G, Carafiello Gp, De Gasperi A et al (2011) Italian guidelines for diagnosis, prevention, and treatment of invasive fungal infections in solid organ transplant recipients. Transpl Proc 43:2463–2471

    Article  CAS  Google Scholar 

  44. Schuster MG, Edwards J, Sobel JD, Darouiche RO, Karchmer AW, Hadley S et al (2008) Empirical fluconazole versus placebo for intensive care unit patients : a randomized trial. Ann Intern Med 149:83–90

    Article  PubMed  Google Scholar 

  45. Garnacho Montero J, Diaz martin A, Marquez Vacaro JA (2012) Management of invasive candidiasis in the critically ill. In: Vincent JL (ed) Annual update in intensive care and emergency medicine. Springer, Berlin, pp 324–336

    Google Scholar 

  46. Senn L, Eggimann P, Ksontini R et al (2009) Caspofungin for prevention of intraabdominal candidiasis in high risk surgical patients. Intensive Care Med 35:903–909

    Article  PubMed  Google Scholar 

  47. Clancy CJ, Hong Nguyen M (2012) The end of an era in defining the optimal treatment of invasive candidiasis. Clin Inf Dis 54:1123–1125

    Google Scholar 

  48. Pereira JM, Paiva JA (2011) Antifungal therapy in the ICU: the bug, the drug, the mug. In: Vincent JL (ed) Annual update in intensive care and emergency medicine. Springer, Berlin, pp 516–530

    Google Scholar 

  49. Moen MD, Lyseng-Williamson KA, Scott LJ (2009) Liposomal amphotericin B: a review of its use as empirical therapy in febrile neutropenia and in the treatment of invasive fungal infections. Drugs 69(3):361–392

    Article  PubMed  CAS  Google Scholar 

  50. Chandrasekar P, Amphotericin B (2008) lipid complex: treatment of invasive fungal infections in patients refractory to or intolerant of amphotericin B deoxycholate. Ther Clin Risk Manag 4(6):1285–1294

    PubMed  CAS  Google Scholar 

  51. Azanza Perea JR, Barberan J (2012) Anfotericina B forma liposómica: un perfil farmacocinético exclusivo. Una historia inacabada. Rev Esp Quimioter 25:17–24

    Google Scholar 

  52. Honore PM, Jacobs R, Spapen HD (2012) Use of antifungals during continuous hemofiltration therapies. In: Vincent JL (ed) Annual update in intensive care and emergency medicine. Springer, Berlin, pp 337–44

    Google Scholar 

  53. Lasse Florl C (2011) Triazole antifungal agents in invasive fungal infections. Comp Rev Drugs 71:2405–2419

    Google Scholar 

  54. Bal AM (2010) The echinocandins: three useful choices or three too many? Int J Antimicrobial Agents 35:13–18

    Article  CAS  Google Scholar 

  55. Mazzei T (2009) Novelli apharmacological properties of antifungal drugs with a focus on anidulafungin. Drugs 69(Suppl. 1):79–90

    Article  PubMed  CAS  Google Scholar 

  56. Bow EJ, Evans G, Fuller J et al (2010) Canadian clinical practice guidelines for invasive candidiasis in adults. Can J Infect Dis Med Microbiol 21:e122–e150)

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Andrea De Gasperi .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2014 Springer-Verlag Italia

About this chapter

Cite this chapter

De Gasperi, A., Cozzi, P., Colombo, S. (2014). Invasive Candidiasis in the Intensive Care Setting. In: Allaria, B. (eds) Practical Issues in Anesthesia and Intensive Care 2013. Springer, Milano. https://doi.org/10.1007/978-88-470-5529-2_13

Download citation

  • DOI: https://doi.org/10.1007/978-88-470-5529-2_13

  • Published:

  • Publisher Name: Springer, Milano

  • Print ISBN: 978-88-470-5528-5

  • Online ISBN: 978-88-470-5529-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics